StockNews.com Upgrades Emergent BioSolutions (NYSE:EBS) to Buy
StockNews.com upgraded shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday. Other equities research analysts have also recently issued reports about the company. Benchmark raised their price target on Emergent BioSolutions from $8.00 to $12.00 and gave the company a […]
StockNews.com Upgrades Select Medical (NYSE:SEM) to “Buy”
StockNews.com upgraded shares of Select Medical (NYSE:SEM – Free Report) from a hold rating to a buy rating in a report issued on Wednesday. Other research analysts have also issued reports about the stock. Benchmark reiterated a “buy” rating and issued a $48.00 target price on shares of Select Medical in a research note on […]
StockNews.com Upgrades Everspin Technologies (NASDAQ:MRAM) to “Buy”
Everspin Technologies (NASDAQ:MRAM – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. Separately, Needham & Company LLC reiterated a “buy” rating and issued a $8.00 target price on shares of Everspin Technologies in a research note […]
Banco Santander (NYSE:SAN) Upgraded to “Buy” at StockNews.com
StockNews.com upgraded shares of Banco Santander (NYSE:SAN – Free Report) from a hold rating to a buy rating in a research note released on Saturday. Separately, UBS Group upgraded shares of Banco Santander from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 4th. Get Our Latest Analysis on SAN Banco […]
StockNews.com Upgrades Unisys (NYSE:UIS) to Buy
Unisys (NYSE:UIS – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. Unisys Trading Up 0.4 % Shares of NYSE:UIS traded up $0.04 during trading on Tuesday, hitting $8.09. 640,065 shares of the stock were exchanged, compared to […]
StockNews.com Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to “Buy”
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. SRPT has been the topic of a number of other reports. Raymond James reaffirmed an “outperform” rating and issued a $150.00 target price on […]
StockNews.com Upgrades Fossil Group (NASDAQ:FOSL) to Buy
Fossil Group (NASDAQ:FOSL – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Fossil Group Stock Up 8.6 % Shares of NASDAQ FOSL traded up $0.10 during midday trading on Monday, hitting $1.26. 485,783 shares of the company’s stock were […]
StockNews.com Upgrades ProAssurance (NYSE:PRA) to “Buy”
ProAssurance (NYSE:PRA – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Other analysts also recently issued research reports about the stock. JMP Securities reduced their price target on shares of ProAssurance from $22.00 to $20.00 and set […]
last updated on 16 Nov 13:40